Table 3. Incidence Rate (IR) of Health Encounters of Interest by Cohort.
| Cohort | Counts (%) | Person Years (PY) | IR per 1,000 PY | CI | |
|---|---|---|---|---|---|
| Obstructive Sleep Apnea Syndrome | Deployed | 10 (50) | 535 | 18.69 | (7.11, 30.27) |
| Balad | 10 (50) | 473.3 | 21.13 | (8.03, 34.23) | |
| Bagram | 0 | 61.7 | 0 | ||
| Non-deployed | 10 (50) | 550.9 | 18.15 | (6.90, 29.40) | |
|
|
|||||
| Diabetes | Deployed | 2 (50) | 546 | 3.66 | (0.44, 13.23) |
| Balad | 2 (50) | 484.3 | 4.13 | (0.50, 14.92) | |
| Bagram | 0 | 61.7 | 0 | ||
| Non-deployed | 2 (50) | 560.5 | 3.57 | (0.43, 12.89) | |
|
|
|||||
| Toxic Effects | Deployed | 1 (50) | 546 | 1.83 | (0.05, 10.20) |
| Balad | 1 (50) | 484.3 | 2.06 | (0.05, 11.50) | |
| Bagram | 0 | 61.7 | 0 | ||
| Non-deployed | 1 (50) | 560 | 1.79 | (0.05, 9.95) | |
|
|
|||||
| Other Specified Personal Exposure | Deployed | 0 | 551.2 | 0 | |
| Balad | 0 | 489.5 | 0 | ||
| Bagram | 0 | 61.7 | 0 | ||
| Non-deployed | 1 (100) | 566.1 | 1.77 | (0.04, 9.84) | |
|
|
|||||
| SSIC Involving Cardiovascular System | Deployed | 8 (47.1) | 535.6 | 14.94 | (4.59, 25.29) |
| Balad | 7 (41.2) | 474.6 | 14.75 | (3.82, 25.68) | |
| Bagram | 1 (5.9) | 61 | 16.38 | (0.41, 91.29) | |
| Non-deployed | 9 (52.9) | 544.6 | 16.53 | (5.73, 27.33) | |
|
|
|||||
| SSIC Involving Respiratory System and Other Chest Symptoms | Deployed | 33 (50) | 475 | 69.47 | (45.77, 93.17) |
| Balad | 30 (45.5) | 418.1 | 71.76 | (46.08, 97.44) | |
| Bagram | 3 (4.5) | 57 | 52.68 | (10.86, 153.95) | |
| Non-deployed | 33 (50) | 479.7 | 68.79 | (45.32, 92.26) | |
|
|
|||||
| Soft Tissue Sarcoma/NHL | Deployed | 1 (25) | 549.7 | 1.82 | (0.05, 10.13) |
| Balad | 1 (25) | 488 | 2.05 | (0.05, 11.42) | |
| Bagram | 0 | 61.7 | 0 | ||
| Non-deployed | 3 (75) | 555.3 | 5.40 | (1.11, 15.79) | |
|
|
|||||
| Neoplasms of Lymphatic/Hematopoietic Tissue | Deployed | 0 | 551.2 | 0 | |
| Balad | 0 | 489.5 | 0 | ||
| Bagram | 0 | 61.7 | 0 | ||
| Non-deployed | 1 (100) | 561.6 | 1.78 | (0.05, 9.92) | |
|
|
|||||
| Disease of the Circulatory System | Deployed | 1 (50) | 549.6 | 1.82 | (0.05, 10.14) |
| Balad | 1 (50) | 487.9 | 2.05 | (0.05, 11.42) | |
| Bagram | 0 | 61.7 | 0 | ||
| Non-deployed | 1 (50) | 565.8 | 1.77 | (0.05, 9.85) | |
|
|
|||||
| Other Lung Diseases Due to External Agents | Deployed | 2 (40) | 540.1 | 3.70 | (0.45, 13.38) |
| Balad | 2 (40) | 478.4 | 4.18 | (0.51, 15.10) | |
| Bagram | 0 | 61.7 | 0 | ||
| Non-deployed | 3 (60) | 559.7 | 5.36 | (1.11, 15.66) | |
|
|
|||||
| Diseases of the Respiratory System | Deployed | 76 (55.1) | 391.9 | 193.95 | (150.34, 237.56) |
| Balad | 61 (44.2) | 344.7 | 176.99 | (132.57, 221.41) | |
| Bagram | 15 (10.9) | 47.2 | 317.76 | (156.95, 478.57) | |
| Non-deployed | 62 (44.9) | 380.4 | 163.00 | (122.43, 203.57) | |